6 Dimensions Capital — 2019 Investments
2 investments dated 2019 · listed companies and verified rows first · show all
A company focused on developing clinical treatments aimed at improving patient outcomes.
BiotechHealthtechMedical DevicesBoston, US
David Southwell(Executive Officer, Director)inRobert Crane(Executive Officer)
BoardLea Hachigian(Director)Steve Kraus(Director)inCampbell Murray(Director)in
Board seatHannes Smarason· per SEC Form D · $23.3M raise · filed Jul 2019
Co-investorsAstellas Venture Management LLCBessemer Venture PartnersGV (Google Ventures)Longwood FundRA CapitalPitango
HiberCell develops therapeutic candidates targeting the Integrated Stress Response pathway to address treatment-resistant cancers, relapse, and metastasis.
BiotechMedical Devices
Julio Aguirre-Ghiso, Ph.D.(Co-Founder)
Co-investorsARCH Venture PartnersMagnetic VenturesRaptor GroupHercules Capital, Inc.Hillhouse Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.












